2018 HORIZONS Speakers

Request Full Agenda

Join us this year at HORIZONS to hear from some of the industry's top though leaders!

We are pleased to announce our first speakers for HORIZONS 2018.  Join us for the chance to listen to these compelling industry movers and shakers. Additional speakers will be announced soon - Watch this space for all of our latest speaker announcements!


FEATURED SPEAKERS


S Kox.png

 

 

 

 



G Dantsker.png

 

 

 


 

Lricci 2.jpg

 

 



 

 

 



Peyton Photo Round.jpg

 


 
 DBarta.jpg

 


Dr. Simon Kos

Chief Medical Officer
Microsoft

Dr. Simon Kos is Chief Medical Officer and Senior Director, Worldwide Health, Microsoft. In this key executive role, Dr. Kos is responsible for providing clinical guidance, thought leadership, vision and strategy for Microsoft technologies and solutions in the Health and Healthcare industries. He works with industry partners and healthcare organizations around the world to improve and transform health outcomes by leveraging technology and innovation. Dr. Kos joined Microsoft in 2010, bringing his expertise to the Australian health team after 17 years in the health and health IT industries. As the doctor on Microsoft’s health team, he was responsible for health strategy and industry engagement. He raised awareness of the Microsoft brand, technologies, and partner community, and he works to find clinical relevance for Microsoft products.

Prior to Microsoft, Dr. Kos worked with global health IT companies Cerner and InterSystems as they implemented some of the largest e-Health initiatives in Australia. Before his career in health IT, Dr. Kos practiced at NSWHealth for several years with a focus on critical care. Simon has an MBBS and a BSc (Med) from the University of New South Wales, as well as an MBA with a major in change management from the Australian Graduate School of Management. He is passionate about improving healthcare through technology.

Dr. Gene Dantkser

Senior Director
Qualcomm Life, Inc.

Dr. Dantsker is responsible for enabling intelligent integrated care models through the Internet of Medical Things (IoMT) in the pharmaceutical, medical device, diagnostics and payer industries. Prior to this role, Dr. Dantsker worked across the spectrum of therapy and diagnostic technology solutions with broad experience in healthcare, biotech and semiconductor businesses. Formerly, he was a senior technical staff member at TRW, Inc., Space and Electronics Division where he was responsible for design, fabrication, and integration of microelectronics for space/satellite applications.

Subsequently he co-founded Nanostream, Inc., a biotechnology company and provider of high-throughput bio-analytical instruments to pharmaceutical companies and CROs. As VP of Technology, Dr. Dantsker was co-inventor and developer of Nanostream’s core technologies based on polymer MEMS microfluidics and converted them into commercial products purchased by leading pharmaceutical companies. He also served as CEO and CTO of aDNAvance Technologies, Inc., a provider of ultra-sensitive medical molecular diagnostic products. Dr. Dantsker served on the Board of Directors of D-Wave Systems, a pioneer in Quantum Computing, with leading Silicon Valley VCs, as well as heavily consulted the company in business development, IP strategy, growth strategy and operational infrastructure.

Linda Ricci
Associate Director, Office of Device Evaluation, Center for Devices and Radiologic Health

U.S. Food and Drug Administration

Linda Ricci began her career developing artificial intelligence solutions in the defense industry before moving to the medical device industry as a software engineer.  She helped to develop several diagnostic cardiology devices and has participated in all phases of product life cycle development.  Ms. Ricci moved to the FDA in 2005 and has had several roles including scientific reviewer and branch chief within the Division of Cardiovascular devices.  Currently Ms. Ricci is the Associate Director for Digital Health within the Office of Device Evaluation.  In this role she, leads the development and implementation of digital health policy within the Office of Device Evaluation.  She has degrees in Electrical Engineering and Medical Engineering.

Desmond Creary
Health Business Leader of the Americas
Microsoft

Desmond Creary is currently the Health Business Leader of the Americas at Microsoft. He previously held several positions at GSK including Vice President of Sales, Primary Care, Field Vice President, and Project Manager for the CEO's Future Strategy Group.  He has a degree in marketing from the Southern University and Agricultural and Mechanical College at Baton Rouge and an MBA from the University of Phoenix

Sarah Luijpers
Associate Vice President, DDO Business Operations
(FACT, Reporting/Analytics & Resourcing)
Allergan

Sarah’s varied background and experience in her 25+ years in the pharmaceutical industry has given her a broad perspective in which she shares with her colleagues daily.  Prior to joining Allergan, Sarah spent ~20 years with Schering Plough (now Merck) starting off as a site monitor and progressing throughout the Clinical Development organization.  Sarah also oversaw all Global Early Stage Development Operations at Schering Plough.  Sarah then transitioned to Forest where she has overseen various groups within Drug Development Operations from Recruitment and Vendor Management, to her current role as Head of DDO Business Operations overseeing, among others, Feasibility Analysis for Clinical Trials (FACT) and Systems and Reporting.

Ritesh Patel
Chief Digital Officer-Health & Wellness
Ogilvy CommonHealth Worldwide

Ritesh is the Chief Digital Officer at Ogilvy CommonHealth Worldwide, a global marketing services company offering advertising and promotion, brand identity and development, digital marketing, market access, medical education, PR, and strategy and planning. Prior to Ogilvy, he spent 5 years as the Global Head of Digital and Innovation for inVentiv Health, a global healthcare services organization with offices in 40 countries. Ritesh is a Digital and Social Evangelist and a geek at heart. With over 18 years of digital experience his background includes Online Marketing, Advertising, Sales, CRM and E-Business. He focuses primarily on digital strategy, tools, platforms, and ecosystems in Healthcare.

Ivan Tarapov
Senior Program Manager: Project InnerEye
Microsoft

Mr. Tarapov is a program manager for Project InnerEye at Microsoft Research. Prior to joining Microsoft Ivan has worked with a number of medical device companies with high-risk devices such as cardiac defibrillators, insulin pumps and deep brain stimulators. 

 

Peyton Howell
Chief Commercial and Strategy Officer
PAREXEL

Peyton Howell joined PAREXEL as Chief Commercial and Strategy Officer in May 2018 and is responsible for leading PAREXEL’s commercial operations to enhance the customer experience.  Ms. Howell’s distinguished career spans over 25 years of delivering solutions that meet the needs of customers in the healthcare industry. 

Ms. Howell previously held several leadership positions with AmerisourceBergen as Executive Vice President and President, Health Systems and Specialty Care Solutions, leading a business unit with market leading share of specialty and biotech products and solutions to physicians, health systems and specialty pharmacy customers. Prior to that, she served as Executive Vice President and President, Global Sourcing and Manufacturer Relations, in which she led all pharmaceutical manufacturer procurement strategy for AmerisourceBergen, including multi-billion dollar sourcing activities.

Douglas Barta
Chief Information Officer
PAREXEL

Mr. Barta currently serves as Chief Information Officer, providing a broad range of knowledge-based contract research, consulting, medical communications, and technology solutions and services to the worldwide pharmaceutical, biotechnology and medical device industries.

Previously Mr. Barta served as CIO of Guy Carpenter, a Marsh & McLennan company and a global leader in providing risk and reinsurance intermediary services. Prior to this position, he served as Chief Operating Officer of Fidelity Investment Management Technology with Fidelity Investments, where he ran operations for Asset Management’s technology division. Mr. Barta also served as SVP IT Transformation and as SVP CFIT, Fidelity’s financial systems business where he held leadership responsibility for Fidelity's ERP and reporting environments as well as spearheading the effort to create and deploy a comprehensive cost and profitability platform.

 
HORIZONS SPEAKERS

Speaker no photo.png
Greg Bandru
Director, Information Management Regulatory Solutions
Pfizer
Greg is a Director in the Information Management, Regulatory Solutions organization.  In this role, Greg is responsible for defining and delivering a variety of regulatory tracking applications, including Pfizer’s InSight implementation.  He also is responsible for the long term vision, strategy, and use of the systems and tools used to aide Regulatory Operations.  Greg consulted with Pfizer since 2001, joined Pfizer in 2017 and holds a BT in Electrical Engineering from Rochester Institute of Technology.

 

 
Andy Chu
Head of Regulatory Systems Strategy

Biogen
Andy has worked across the Life Sciences and Pharma Industry over the past 25 years, across the multiple disciplines, businesses, and capabilities of R&D.  As the Head of Regulatory Information Management and Data Sciences (RIM DS) at Biogen, he drives how the regulatory function brings together its technology, data, processes and people to enable strategic objectives by developing the vision of RIM, evolving the Regulatory core capabilities against this vision, and providing an operating framework supporting the use of these capabilities

 

Speaker no photo.png
David Fisher
Director, Regulatory Information Management
Allergan
David Fisher is Allergan’s Director of Regulatory Information Management. David joined the company in Marlow, UK in 2008 as part of the R&D IS team, he relocated to Irvine, CA in 2012 where he continued leading the IS Support teams across multiple R&D business areas including Regulatory.  David transitioned into his current role in 2016 where he now leads a small team and provides global leadership for the growing Global RIM function.

 


Robert Jarrin

Senior Director, Wireless Health Public Policy
Qualcomm Incorporated
Lead Qualcomm’s regulatory, policy and legislative efforts pertaining to wireless health and life sciences. Areas of responsibility include:  federal and state HIT policy; FDA regulatory oversight of converged medical devices; congressional legislative health affairs; medicare and  medicaid telehealth reimbursement; FCC broadband healthcare efforts.

 

 
Bryan Morganti
Business Partner/Manager, Business Technology
Pfizer
Bryan works in the Business Technology organization at Pfizer as a Business Partner/Manager, working within the Worldwide Safety Regulatory and Medical department.  He joined Pfizer in 2008 in an application support role supporting many of the regulatory publishing applications and moved to the Business Partner role shortly after to manage the applications he previously supported.  Bryan has worked in a role supporting Submission Publishing applications and processes since 2005.  Over the past few years he has also been focusing on how to automate different repeatable functions in these areas to increase productivity while maintaining the high level of accuracy required to be successful.  He also holds a BS from the University of Connecticut.


 Speaker no photo.png
Lisa M. Owens, MBA
Director, Regulatory Operations
BeiGene
Lisa holds a BA in Political Science and Philosophy from San Diego State University and an MBA from the Paul Merage School of Business, University of California Irvine.  She has 18 years of industry experience with Regulatory, Regulatory Operations and Project Management.  In 2003, she filed the first official eCTD through the centralized procedure in Europe.  Since then, Lisa has worked with several companies implementing software systems, global Regulatory Operations best practices, and building departments and teams.  She has managed teams in the US and the UK, where she lived for 5 years.  She is currently a Director of Regulatory Operations within BeiGene managing a global team of project managers, publishers, and other RO professionals across the US and China.

 

 
Shailesh Vyas
Director, Business Information Management, Global Regulatory Affairs & ECM - R&D IT
Allergan
Shailesh Vyas joined Allergan (Actavis) in January 2014 within the R&D IT group, and is responsible for managing Global Regulatory Affairs and R&D Content Management systems. With regulatory information management and submission document management as core skills, he is serving as Regulatory IT lead on key R&D IT initiative of building end-to-end regulatory processes and systems on PAREXEL cloud. Before joining Allergan, Shailesh worked at Merck and Schering-Plough for 15 years supporting various R&D systems.

 


Paul Bidez
Vice President Regulatory & Clinical Solutions
PAREXEL

Paul joined PAREXEL in the summer of 2015 to lead the Regulatory Solutions business and provide innovative, industry-leading technologies and services that help to deliver on the missions of global regulatory organizations. These capabilities include the full suite of regulatory enabling technologies within the INSIGHT platform as well as industry-leading teams of experienced regulatory professionals well versed in the best practices for the global management of regulatory information.

 


Jo English
Senior Director of Client Enablement
PAREXEL
Jo is a specialist in global regulatory affairs and operations with over 25 years of experience in the biopharmaceutical industry. She also has 15+ years’ experience in registration information management, submission management and dossier publishing. Jo leads a team of solution design experts with her team at to provide strategic regulatory input and designs client solutions for the RIM suite. Jo has her BSc in Microbiology

 


Tim Gilbert
Senior Director, Product Management
PAREXEL
Tim has spent over 25 years in the Communications and more recently Healthcare industries. He has held various senior roles across those spaces and currently heads up Product Management for PAREXEL’s Randomization and Trial Supply Management service. He has a software engineering degree and is passionate about progressing the combination of people and technology to bring medicines to market, safer, faster and more efficiently.

 

Zizi.jpg
Zizi Imatorbhebhe, MS MBA PMP

Senior Director, Strategic Development, Head PAREXEL RARE Disease Initiative
PAREXEL
Zizi brings 29 years of Bio-Pharmaceutical and Clinical Research industry experience. Her background has included working with small and large bio-pharma companies to identify potential challenges and solutions to ensure successful early and late phase clinical operational strategies - and ultimately, shorten clinical development timelines. She is the Head of PAREXEL’s Rare Disease Initiative including its Center of Excellence, a dedicated cross functional team that addresses strategic, operational and medical challenges faced in managing rare disease studies.   Some of her previous employers prior to PAREXEL include PPD, McKesson and  Glaxo Smith Kline among others.  Her functions have included Strategy Development, Alliance Management, Marketing, Sales, Clinical Operations Management and Clinical Research.

 

 
Matt Petrella
Senior Director of Client Enablement
PAREXEL

Matt is currently responsible for management, development and oversight for managing customer relationships, delivering services and implementing technologies to PAREXEL’s customers. He supports clients through the facilitation of their clinical trials while providing the appropriate technical integration and clinical technologies (CTMS, EDC, IRT/IVRS, medical imaging and regulatory). Matt is a subject matter expert in the area of clinical technology platforms combining a unique operational and technical background to identify and integrate the solutions into the business. He focuses on customer satisfaction, excellence in delivery and the nurturing of a longer term partnership with our global clients.

 

B Puglia.jpg
Bill Puglia

Global Head Solutions Management
PAREXEL
Bill has more than 25 years of experience in diverse roles to drive the introduction of ‘first of kind’ digital solutions underpinned by predictive analytics across multiple industries (power generation, oil and gas, petrochemical, aerospace).  Bill was elected as a Rolls Royce Engineering Fellow in 2014 and is a Mechanical Engineer from MIT by education. Bill joined PAREXEL Informatics in 2015 as a Senior Director to lead a newly formed Solution Incubator group within Engineering.  This team developed and launched PAREXEL’s Patient Sensor Solution and joint research project with Sanofi.   In his current role, Bill is responsible for driving PAREXEL growth and market innovation by orchestrating solution, product, service, marketing and business development teams to identify and prioritize new business opportunities for Patient Technology Solutions and Services which includes medical imaging, RTSM, eCOA and sensors. 

 

 

Speaker no photo.png
Greg Bandru
Director, Information Management Regulatory Solutions
Pfizer
Greg is a Director in the Information Management, Regulatory Solutions organization.  In this role, Greg is responsible for defining and delivering a variety of regulatory tracking applications, including Pfizer’s InSight implementation.  He also is responsible for the long term vision, strategy, and use of the systems and tools used to aide Regulatory Operations.  Greg consulted with Pfizer since 2001, joined Pfizer in 2017 and holds a BT in Electrical Engineering from Rochester Institute of Technology.

 

 
Andy Chu
Head of Regulatory Systems Strategy

Biogen
Andy has worked across the Life Sciences and Pharma Industry over the past 25 years, across the multiple disciplines, businesses, and capabilities of R&D.  As the Head of Regulatory Information Management and Data Sciences (RIM DS) at Biogen, he drives how the regulatory function brings together its technology, data, processes and people to enable strategic objectives by developing the vision of RIM, evolving the Regulatory core capabilities against this vision, and providing an operating framework supporting the use of these capabilities

 

Speaker no photo.png
David Fisher
Director, Regulatory Information Management
Allergan
David Fisher is Allergan’s Director of Regulatory Information Management. David joined the company in Marlow, UK in 2008 as part of the R&D IS team, he relocated to Irvine, CA in 2012 where he continued leading the IS Support teams across multiple R&D business areas including Regulatory.  David transitioned into his current role in 2016 where he now leads a small team and provides global leadership for the growing Global RIM function.

 


Robert Jarrin

Senior Director, Wireless Health Public Policy
Qualcomm Incorporated
Lead Qualcomm’s regulatory, policy and legislative efforts pertaining to wireless health and life sciences. Areas of responsibility include:  federal and state HIT policy; FDA regulatory oversight of converged medical devices; congressional legislative health affairs; medicare and  medicaid telehealth reimbursement; FCC broadband healthcare efforts.